These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26634380)

  • 1. Slow walking speed may be early sign of Alzheimer's in older people, study finds.
    Mayor S
    BMJ; 2015 Dec; 351():h6506. PubMed ID: 26634380
    [No Abstract]   [Full Text] [Related]  

  • 2. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
    Nordberg A
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1540-3. PubMed ID: 15372212
    [No Abstract]   [Full Text] [Related]  

  • 3. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
    Hardy J
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1539-40. PubMed ID: 15372211
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of regional brain β-amyloid to gait speed.
    Del Campo N; Payoux P; Djilali A; Delrieu J; Hoogendijk EO; Rolland Y; Cesari M; Weiner MW; Andrieu S; Vellas B;
    Neurology; 2016 Jan; 86(1):36-43. PubMed ID: 26643548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for a specific neuroradiologic diagnosis of Alzheimer's disease.
    Blass JP
    J Nucl Med; 2002 Aug; 43(8):1052-3. PubMed ID: 12163631
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular neuroimaging in Alzheimer's disease.
    Matsuda H; Imabayashi E
    Neuroimaging Clin N Am; 2012 Feb; 22(1):57-65, viii. PubMed ID: 22284733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease.
    Kincaid E
    Nat Med; 2016 Oct; 22(10):1067-1068. PubMed ID: 27711060
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid + activation = Alzheimer's?
    Jagust W
    Neuron; 2009 Jul; 63(2):141-3. PubMed ID: 19640471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
    Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
    Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
    J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
    Leyton CE; Villemagne VL; Savage S; Pike KE; Ballard KJ; Piguet O; Burrell JR; Rowe CC; Hodges JR
    Brain; 2011 Oct; 134(Pt 10):3030-43. PubMed ID: 21908392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid Hypothesis: The Emperor's New Clothes?
    Høilund-Carlsen PF; Barrio JR; Werner TJ; Newberg A; Alavi A
    J Alzheimers Dis; 2020; 78(4):1363-1366. PubMed ID: 33164938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is amyloid-β harmful to the brain? Insights from human imaging studies.
    Jagust W
    Brain; 2016 Jan; 139(Pt 1):23-30. PubMed ID: 26614753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
    Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.